BET1 and congestive heart failure: Thus, BPC 157 therapy as applied as intragastric application, per-oral in drinking water, might exert the reversal of the doxorubicin-induced congestive heart failure, effective even in the advanced status of failing heart in rats and mice studied by the reversal of the BET-1 plasma level [84].